104 related articles for article (PubMed ID: 3713694)
1. [Management of malignant ascites with a streptococcal preparation, OK-432: induction of growth inhibition factor(s) against tumor cells].
Katano M; Yamamoto H; Hisatsugu T
Nihon Geka Gakkai Zasshi; 1986 Apr; 87(4):471. PubMed ID: 3713694
[No Abstract] [Full Text] [Related]
2. [The management of malignant ascites with a streptococcal preparation, OK-432: relation between the clinical effect and auto-tumor cell killing activity by OK-432-induced ascites-derived lymphocytes].
Katano M; Yamamoto H; Mizoguchi T; Hidaka K; Hisatsugu T; Torisu M
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2464-8. PubMed ID: 3497612
[TBL] [Abstract][Full Text] [Related]
3. New approach to management of malignant ascites with a streptococcal preparation, OK-432. II. Intraperitoneal inflammatory cell-mediated tumor cell destruction.
Katano M; Torisu M
Surgery; 1983 Mar; 93(3):365-73. PubMed ID: 6600854
[TBL] [Abstract][Full Text] [Related]
4. [Intratumor injection of OK-432-stimulated peripheral blood mononuclear cells: a significance of mononuclear cell-producing tumor inhibitory factor induced by OK-432].
Mizoguchi T; Katano M; Yamamoto H; Hisatsugu T
Nihon Geka Gakkai Zasshi; 1987 Jun; 88(6):794. PubMed ID: 3627102
[No Abstract] [Full Text] [Related]
5. New approach to management of malignant ascites with streptococcal preparation OK-432. III. OK-432 attracts natural killer cells through a chemotactic factor released from activated neutrophils.
Hayashi Y; Torisu M
Surgery; 1990 Jan; 107(1):74-84. PubMed ID: 2404351
[TBL] [Abstract][Full Text] [Related]
6. [TNF induction in the serum and ascites of a gastric cancer patient treated with OK-432].
Neda H; Watanabe N; Sone H; Yamauchi N; Niitsu Y; Urushizaki I
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):593-7. PubMed ID: 3954382
[TBL] [Abstract][Full Text] [Related]
7. [Induction of the human tumor necrosis factor (h-TNF) by the streptococcal preparation, OK-432--a clinical trial in 10 lung cancer patients with pleural fluid].
Miyai M; Matsuka Y; Tsubota T; Asano K
Nihon Gan Chiryo Gakkai Shi; 1986 Jul; 21(6):1285-91. PubMed ID: 3782979
[No Abstract] [Full Text] [Related]
8. [Clinical evaluation of immunochemotherapy with streptococcal preparation "OK-432" on inoperable advanced cancers (author's transl)].
Nio Y; Nitta N; Tanaka A; Ichikawa T; Henmi K
Nihon Geka Hokan; 1981 Sep; 50(5):704-10. PubMed ID: 7332399
[No Abstract] [Full Text] [Related]
9. New approach to management of malignant ascites with a streptococcal preparation, OK-432. I. Improvement of host immunity and prolongation of survival.
Torisu M; Katano M; Kimura Y; Itoh H; Takesue M
Surgery; 1983 Mar; 93(3):357-64. PubMed ID: 6187080
[No Abstract] [Full Text] [Related]
10. Induction of tumor necrosis factor by administration of OK-432 in cancer patients.
Kokunai I; Shimano T; Sekimoto K; Takeda T; Kobayashi T; Yayoi E; Yamamoto A; Mori T
J Clin Lab Immunol; 1986 Dec; 21(4):169-71. PubMed ID: 3560194
[TBL] [Abstract][Full Text] [Related]
11. [Management of malignant ascites by intraperitoneal injection of OK-432. Possible mechanism of the reduction of original tumor mass volume].
Katano M; Mizoguchi T; Yamamoto H; Hisatsugu T; Torisu M
Nihon Geka Gakkai Zasshi; 1987 Dec; 88(12):1676-83. PubMed ID: 3447033
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of induction of endogenous tumor necrosis factor in ascites of ovarian cancer patients by OK-432, a streptococcal preparation.
Mori H; Itoh N; Tamaya T
Immunopharmacol Immunotoxicol; 1989; 11(1):33-53. PubMed ID: 2503555
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of a skin test (SU-PS) for immune responses in patients with gastrointestinal cancer treated with OK-432].
Miyamoto Y; Takeshita M; Izuo M
Gan To Kagaku Ryoho; 1986 Oct; 13(11):3229-35. PubMed ID: 3777960
[TBL] [Abstract][Full Text] [Related]
14. [Adoptive immunotherapy of murine tumors using cultured syngeneic tumor-bearer-spleen cells. II: Therapeutic effect of cultured lymphocytes against malignant ascites and its augmentation by the streptococcal preparation, OK 432].
Kan N; Inamoto T; Hori T; Nio Y; Tsuchitani T; Kodama H; Tobe T; Ohgaki K
Nihon Gan Chiryo Gakkai Shi; 1985 May; 20(4):784-96. PubMed ID: 3877129
[No Abstract] [Full Text] [Related]
15. [Treatment of malignant ascites. II. Immunological studies on disappearance of ascites by intraperitoneal injection of a streptococcal preparation, OK-432 (author's transl)].
Katano M
Fukuoka Igaku Zasshi; 1981 Oct; 72(10):543-55. PubMed ID: 7327499
[No Abstract] [Full Text] [Related]
16. Induction of tumor growth inhibitory factor (TGIF) in human mononuclear cells by OK-432, a streptococcal preparation.
Katano M; Yamamoto H; Mizoguchi T; Hisatsugu T
Cancer Immunol Immunother; 1988; 27(3):198-204. PubMed ID: 3141056
[TBL] [Abstract][Full Text] [Related]
17. Immunological parameters in gastric cancer patients treated with immunotherapy of streptococcal preparation OK-432.
Hanaue H; Nomoto S; Kimura T; Kutsuna T; Takeuchi T; Yoshizaki S
Keio J Med; 1982 Dec; 31(4):159-68. PubMed ID: 6985379
[No Abstract] [Full Text] [Related]
18. Therapeutic effect of OK-432 induced endogenous TNF on tumor bearing mice and cancer patients.
Watanabe N; Niitsu Y; Yamauchi N; Neda H; Sone H; Urushizaki I; Yamamoto A; Nagamuta M; Sugawara Y
Immunopharmacol Immunotoxicol; 1988; 10(1):53-65. PubMed ID: 3361071
[TBL] [Abstract][Full Text] [Related]
19. Malignant ascites treated with streptococcal extract.
Lancet; 1983 Jun; 1(8336):1258. PubMed ID: 6134047
[No Abstract] [Full Text] [Related]
20. [Role of the spleen in OK-432 immunotherapy and characterization of effector cells].
Yamagishi H; Naito K; Maeda Y; Kobayashi M; Kurioka H; Fujimori C; Tanaka T; Hashimoto I
Gan To Kagaku Ryoho; 1983 Jul; 10(7):1670-8. PubMed ID: 6870309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]